Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 6,068,125 | 6,068,125 | 0 | $244.97M | $187.63M | 63.50% | -$57.34M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,025,000 | 1,025,000 | 0 | $22.15M | $24.39M | 8.26% | +$2.24M |
| Verona Pharma plc (VRNA)ADS | 1,115,352 | 1,115,352 | 0 | $22.17M | $17.95M | 6.07% | -$4.23M |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | $1.52M | $14.54M | 4.92% | +$13.02M |
| Biomea Fusion, Inc.(BMEA) | 798,757 | 798,757 | 0 | $11.60M | $11.94M | 4.04% | +$343.5K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,472,331 | 1,472,331 | 0 | $8.32M | $10.38M | 3.51% | +$2.06M |
| Nuvation Bio Inc.CL A(NUVB) | 2,541,009 | 2,541,009 | 0 | $3.84M | $9.25M | 3.13% | +$5.41M |
| COMPASS Pathways plcADS(CMPS) | 964,500 | 964,500 | 0 | $8.44M | $8.02M | 2.72% | -$414.4K |
| Poseida Therapeutics Inc. (PSTX) | 1,043,267 | 1,043,267 | 0 | $3.51M | $3.33M | 1.13% | -$177.4K |
| CalciMedica, Inc.(CALC) | 0 | 521,114 | +521,114 | $0 | $2.17M | 0.73% | +$2.17M |
| Reneo Pharmaceuticals Inc (RPHM) | 886,075 | 886,075 | 0 | $1.42M | $1.47M | 0.50% | +$53.2K |
| Marker Therapeutics, Inc.(MRKR) | 314,286 | 314,286 | 0 | $1.73M | $1.35M | 0.46% | -$377.1K |
| Avrobio, Inc. (AVRO) | 1,009,779 | 1,009,779 | 0 | $1.37M | $1.29M | 0.44% | -$80.8K |
| Spruce Biosciences, Inc. (SPRB) | 1,205,511 | 1,205,511 | 0 | $3.53M | $947.5K | 0.32% | -$2.58M |
| Aclaris Therapeutics, Inc.(ACRS) | 434,455 | 434,455 | 0 | $456.2K | $538.7K | 0.18% | +$82.5K |
| Viracta Therapeutics Inc (VIRX) | 288,571 | 288,571 | 0 | $164.5K | $294.3K | 0.10% | +$129.9K |
| Atreca Inc. (BCEL)CL A | 387,653 | 0 | -387,653 | $51.2K | $0 | — | -$51.2K |